Because we found that the postivity of ER or PR in Chinese women with ovarian cancer is similar to that of other ethnicities, it is important to investigate in the future whether the younger age at diagnosis in Chinese women could explain their better clinical outcomes. The gene discussed is ESR1; the disease is ovarian cancer.